(Q46804069)

25 December 2017

title

Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study (English)

1 reference

25 December 2017

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

P Riley

1

1 reference

25 December 2017

D Sudarshi

2

1 reference

25 December 2017

M Johal

3

1 reference

25 December 2017

A Benedict

4

1 reference

25 December 2017

J Panteli

5

1 reference

25 December 2017

M Crook

6

1 reference

25 December 2017

J O'Donohue

7

1 reference

25 December 2017

publication date

14 January 2008

1 reference

25 December 2017

International Journal of Clinical Practice

published in

1 reference

25 December 2017

volume

62

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

374-381

1 reference

25 December 2017

Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Weight gain as a risk factor for clinical diabetes mellitus in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Prevention and treatment of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Effect of weight control on hepatic abnormalities in obese patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01666.X

10.1111/J.1742-1241.2007.01666.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017